Innovation Through Collaboration

2023 iC³ Sessions

Thursday, September 28, 2023: 7:30am - 6:30pm

Friday, September 29, 2023: 8:00am - 3:30pm

Irving Convention Center at Las Colinas

Resilience: The State of Biotech in Texas

Texas is well known for its determination and independence. What is not well known is that Texans are collaborative and are working together to make a difference in the bioscience industry in the Lone Star State.

Hear from Ernst & Young when they present the Texas version of their global Beyond Borders – Biotechnology Report. With insights into capital allocation strategies, investor perspectives, financial performance, and other key topics, the EY yearly analysis of the state of our industry helps global biotech leaders forge a path towards operational resilience and long-term value creation.

  • Sid Backstrom, JD

    Chief Administrative Officer

    G-CON Manufacturing

  • Eva Hevron

    Partner

    Ernst & Young

  • Anil Kumar, PhD, MS

    Economic Policy Advisor and Senior Economist

    Federal Reserve Bank of Dallas

  • Larry McManus

    Director of Business and Community Development

    Office of Texas Governor Greg Abbott

  • Todd Skrinar, MBA

    Principal, US-West Health Sciences & Wellness Market Segment Leader

    Ernst & Young

Cell & Gene Therapy – Wild West and the Next Frontier

Hear from experts provide the brief primer of history, advances, and implications of CGT in the USA, highlight CGT pioneers in Texas and discuss how we are advancing the industry here in this region.

  • Tania Martin-Mercado, PhD, MS, MPH

    President & CEO, Chief Scientist

    Phronetik

  • Berge Minassian, MD

    Division Chief of Pediatric Neurology

    UT Southwestern Medical Center

  • Vincent Shier, PhD

    Partner

    Haynes and Boone

  • Michael Stewart, PhD

    COO

    Matica Biotechnology

Texas as a Collaborative, Diverse Bioscience Ecosystem

Texas has become a haven for bioscience research and technology by taking a holistic approach and creating a collaborative, accessible ecosystem for innovation to thrive.

Learn from industry executives and institutional research leaders exactly how and why, the future is bright in North Texas.

  • Jenny Ligon

    Senior Associate Director

    National Center for Therapeutics Manufacturing

  • Komel Grover, MBA

    President & CEO

    Swiss American CDMO

  • Rupa Iyer, PhD

    Vice President of Research, Innovation and Economic Development

    Tarleton State University

  • Jason Mastoris

    Co-Founder

    Panthera Biosolutions

Insights for Addressing Pharma-Logistics Supply Chain Challenges

Often overlooked, but critical to the success of maintaining product integrity across the end-to-end supply chain.

Hear from industry supply chain leaders on how to avoid common pitfalls, mitigate risk, and build supply chain resilience.

  • Milton De La Paz

    Vice President of Airlines Relations & Cargo Business

    DFW International Airport

  • Greg Malter

    District Manager

    Expeditors

  • Brian Hodges

    Director of Customer Insights, Products & Engagement

    American Airlines

  • Steve Vondra

    Vice President of Operations & Sales

    SCL Cold Chain, LLC

  • Victoria Wilmore

    Global Temperature Control Support Center Director

    Johnson & Johnson

Begin with the End in Mind

The path to funding is rarely easy for an early-stage life science company. Implementing key practices early on can help you prepare for the future and identify issues that may create problems later.

Understanding which key milestones investors seek can help you know when to engage and how to prepare in advance. Learn what sets companies apart and how to put your best foot forward.

  • Milad Alucozai, MSc, MPH, DrPH

    Head of Bio and Deep Tech

    BoxOne Ventures

  • James Byrd, MS

    Partner and IPO Readiness Leader

    Deloitte

  • Michael Carr, MBA

    Former President and CEO

    Calyxt 

  • Bonnie Jarecke

    Partner

    Deloitte

  • Courtney Tygesson, JD

    Partner

    Cooley

Commercial Launch Success Stories From the Four Corners of Texas

Executive leaders from life sciences will speak on different stages of the drug launch life cycle, and discuss challenges, opportunities, and futures to provide perspective for other companies embarking on the same journey.

Hear tangible examples of successes, pitfalls-and how to avoid them, as well as personal stories from commercial launches.

  • Dave Lowrance

    CFO

    Savara, Inc.

  • Michael Marquez

    CFO

    Nanoscope Therapeutics

  • Zachary Nelson, MBA

    Texas Life Sciences Consulting Leader

    RSM US LLP

  • Joe Payne

    Vice President of Quality and Regulatory Affairs

    Scorpius Biomanufacturing

  • Anthony Placencio

    Partner

    RMSM US LLP

  • Greg Salcido, MPA

    CFO

    Arugula Sciences

Investing Strategies and Trends in the MedTech Industry

Listen to a powerhouse panel of investors who share their perspectives on how the current market dynamics and trends are influencing med device growth in North Texas.

  • Gwen Watanabe, MBA, MS

    Managing Director

    H.I.G. Capital

  • Carter Meyer, JD

    Founder & Managing Partner

    View Ventures

  • Jonathan Norris, JD

    Managing Director

    HSBC Innovative Banking

  • Chad Ronholdt, MBA

    Managing Director

    NVB Ventures

Roadmap to Innovation: Hot Topics in Regulatory, Quality and Data Protection

Meeting the expectations of regulators during product development and commercialization is the key driver of the biotech industry. Our regulatory, quality, and data protection experts will be discussing some of today’s hottest topics.

  • Cheryl Beal Anderson, PharmD, MBA

    Chief Executive & Founder

    ACE Regulatory Affairs Consulting

  • Bobbi Drais, MS, RAC

    President / Principal Consultant

    Drais Regulatory Consulting, LLC

  • Julie Liambotis

    US Director and Data Protection Manager

    MyData-TRUST

  • Massoud Motamed, PhD

    Vice President of Quality

    Nanoscope Therapeutics

  • Trey Putnam, PhD, RAC

    Vice President of Regulatory Affairs and Quality

    Osteal Therapeutics

Development of a Cell & Gene Therapy Ecosystem in North Texas Fireside Chat

A successful biotech ecosystem requires solid, broad-reaching foundational research, strength through intellectual property, targeted commercial development, establishing manufacturing capabilities, corporate partnerships, and capital investment.

In this chat, we will discuss the keys to building an effective ecosystem in North Texas.

  • Adrian Denvir, PhD

    Director of SBIR Programming

    UNT Health Science Center

  • Gerry Farrell, PhD

    Chief Operating Officer

    Fujifilm Diosynth Biotechnologies

  • Vincent Shier, PhD

    Partner

    Haynes and Boone

The Physical Space of Biopharma Manufacturing

Biopharma is the intersection of biotechnology and pharmaceutical manufacturing. This panel will discuss the physical spaces required to bring these revolutionary technologies, including cell and gene therapy, to the public.

  • Patricia Larrabee, MS

    President

    Facility Logix

  • Thomas Page, PhD

    Senior Vice President of Operational and Technology Alignment

    FujiFilm Diosynth Biotechnologies

  • Joe Payne

    Vice President of Quality and Regulatory Affairs

    Scorpius Biomanufacturing

  • Bill Poole

    Regional Director of Business Development

    EwingCole / ECBuild

Resources for Startups

Starting a Bio/Health/Med Tech company can be hard, but you don’t have to do it alone! North Texas is full of fantastic resources for new and seasoned entrepreneurs.

In this panel, you will hear from local industry experts as we dive into topics including funding, business fundamentals, IP strategy, and risk management.

  • Adrian Denvir, PhD

    Director of SBIR Programming

    UNT Health Science Center

  • Gabby Everett, PhD

    Director of Business Operations & Strategy, Site Head

    BioLabs Pegasus Park

  • Kristin Lonergan, CIC

    Market President, DFW

    Cadence Insurance

  • Edward Meagher, JD

    Partner

    Carter DeLuca & Farrell LLP

  • Tiffanie Tovar

    Senior Community Manager

    MassChallenge

Rising Stars

Rising Stars are the next generation leaders tackling the biggest challenges in healthcare and life sciences exhibiting recent noteworthy achievements.

Listen to these North Texas based companies in the life science and healthcare innovation industry who are making a big impact in the community.

The Value of Having a Strategic Investor or Partner on Your Team

Having an investor or partner with knowledge and experience in your particular market can provide your company with a competitive advantage, reducing risks, and accelerating your growth.

Their insights, relationship connections, and expertise can be instrumental in achieving long-term success.

  • Cyonna Holmes, PhD

    Global Strategy Leader Pharmaceutical Solutions Ophthalmology,

    Rare Diseases, RNA

    Celanese

  • Allison Rhines, MBA, PhD

    Head of JLABS @ TMC

    Johnson & Johnson Innovation

  • Erik Ringberg, MBA

    Healthcare Distribution and Diagnostics Executive – VP/GM Lab

    McKesson

  • Margaret Sampson, PhD, JD

    Partner

    McDermott Will & Emery

  • April Stanley, MS, MBA

    Life Sciences Associate

    Echo Investment Capital

How and Where is AI Impacting the Biopharma Industry?

AI and Machine Learning are a part of our economy.  Join us and hear Key Opinion Leaders discuss the future of AI and its impact on the Biopharma Industry - facilitating and accelerated innovation and precision in medicine.

  • Claire Aldridge, PhD

    Chief Strategy Officer

    Form Bio

  • David Gascoigne

    CEO

    Almaden Genomics

  • Josh Seidenfeld, JD, MBA

    Chair of Digital Health Practice

    Cooley

  • Panna Sharma

    President & CEO

    Lantern Pharma

  • Gabriela Wilson, PhD, FHIMSS, SNAI, FIAHSI

    Director of Health & Public Health Informatics

    The University of Texas at Arlington

A Blunt Conversation About the Cost of Conversions

North Texas is ripe with spec warehouses, office space, and land for development, but there are many “costs” to consider when deciding on a location for your life science facility.

Panelists will discuss financial considerations, the cost of time in the race to market, environmental costs, tradeoffs, lessons learned, and more.

  • Ken Anthony, MS

    Vice President of Life Science

    Haskell

  • Jeremy Kinsel

    Director of Preconstruction

    BE&K Building Group

  • Hardik Patel

    Co-Founder

    Panthera Biosolutions

  • Chelsea Story

    Vice President. Occupier Advisory & Transaction Services

    CBRE

Tech Transfer Office Showcase and Pitch Competition

Listen to academic institutions across Texas showcase their best technologies that are available for licensing, collaboration and/or acquisition.

  • Hayden Blackburn

    Executive Director

    TechFW

  • Tricia D'Cruz

    Founder & Managing Director

    Catalyze Dallas

  • Nasreen Jacobson, PhD, MS

    President/Owner

    Kenatha Scientific Consulting, LLC

  • Allison Rhines, MBA, PhD

    Head of JLABS @ TMC

    Johnson & Johnson Innovation

  • Chad Ronholdt, MBA

    Managing Director

    NVB Ventures

  • Supriya Sinha, MS, PhD

    Assistant Director, Commercialization Relations

    UT Southwestern Medical Center

Innovation and the Future of Med Device in North Texas

Come listen to what the future of medical devices looks like from different perspectives; you’ll hear about how advancements in 3D printing of implants can lower healthcare costs and how biologics are merging with devices and transforming clinical outcomes.

  • Robert Bearden, PhD

    Director of Research, Technology and Innovation

    Smith & Nephew

  • John Davidson

    President

    Acuity Surgical

  • Steve Guengerich, MBA

    Associate Vice President, Innovation & Commercialization

    The University of Texas at Dallas

  • Gregory Howison, JD

    Partner

    Munck Wilson Mandala